Re: Patient Enrollment Modeling
in response to
by
posted on
Dec 07, 2018 11:35AM
One more tidbit of info for BETonMACE vs. EXAMINE AND ELIXA. The median time from ACS event to randomization in study is 34 days, 45 days and ~60 days, respectively, for BETonMACE, EXAMINE and ELIXA. More evidence of BETonMACE patients having super high residual risk.
BDAZ